Washington

As a top 10 global hub for innovation, Washington State's life sciences ecosystem is a powerhouse of biotechnology and pharmaceutical advancement.

The region is internationally recognized for its leadership in cell and gene therapy, largely driven by the pioneering legacy of bone marrow transplantation and immunotherapy research.

World-class academic research institutions, such as the University of Washington and the Fred Hutchinson Cancer Center, serve as the backbone for the state's robust biomedical research pipeline.

In the medical device sector, Washington excels in diagnostic imaging, ultrasound technology and the development of electromedical apparatuses.

The ecosystem is further strengthened by a unique convergence of healthcare innovation and digital health, where the region's deep roots in cloud computing and artificial intelligence accelerate AI-driven drug discovery.

With over 1,100 companies, including global leaders in infectious disease and global health, the state offers a collaborative environment for both biotech startups and established biopharma giants.

This synergy between tech disruptors and life science researchers fosters a high-growth market for precision medicine and bioinformatics. Supported by a highly skilled STEM workforce and significant NIH grant funding, Washington remains a premier destination for life sciences investment and commercialization.